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Joint diseases include several conditions that have great impact on
society, such as rheumatoid arthritis or osteoarthritis. Tissue en-
gineering is one of the most promising alternatives to overcome the
low capacity of cartilage self-repair in those debilitating diseases
context.
Chitosan-polybutylene succinate (C-PBS) scaffolds have been
studied for their suitability for cartilage tissue engineering. Pre-
vious works have shown that these scaffolds support chondrocytes
primary cultures, its growth and ECM production. C-PBS ﬁber
meshes were produced by ﬁber extrusion, followed by hot com-
pression, producing a 3D non-woven mesh of variable pore size.
These ﬁber meshes were used for supporting human mesenchymal
stem cells (hMSCs) chondrogenic differentiation.
hMSCs isolated from human bone marrow were expanded until
passage 2. Afterwards, 1 million cells were statically seeded in
each C-PBS ﬁber mesh, in a total of 20. Then, constructs were
transferred to a ﬂow perfusion bioreactor. Perfusion rate was
0,1mL/h per scaffold. Constructs were cultured for 28 days, with
chondrogenic differentiation medium. Differentiation was evalu-
ated by SEM, histology and immunolocalisation of collagens.
Preliminary results indicate that cells are able to proliferate and to
differentiate into chondrocytes, at 14 days of culture. Results in-
dicate that C-PBS ﬁber meshes are able to support hMSCs chon-
drogenic differentiation and extracellular matrix production.
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Aims: Modern tissue engineering solutions use scaffolds, cells and
growth factors. We present an innovative oriented scaffold con-
cept. For three dimensional characterization we used a new method
and compared the data with histomorphological techniques.
Methods: Scaffold design: Scaffolds were synthesized using a
freeze structuring procedure. Gelatine from porcine skin was dis-
solved and partly amended by previously synthesized PLGA mi-
crospheres for release of signalling molecules. The solutions were
directionally frozen, freeze-dried and chemically cross-linked in
aldehyde-saturated atmosphere followed by detoxiﬁcation. Cell
culture: Bovine chondrocytes were cultivated on different scaffold
modiﬁcations. After 8 days histology and histochemistry were
performed.
Three-dimensional characterization: The three dimensional
structure as well as the cell and microsphere distribution were
analyzed by synchrotron-generated X-rays (SR-mCT) without any
metal labelling using the Berlin synchrotron facility BESSY.
Results: After 8 days the chondrocytes maintained a chon-
drocytic phenotype, with synthesis of extracellular matrix as
shown by alcian blue staining. The three dimensional character-
ization of the scaffold by SR-mCT revealed the orientation of the
scaffold ﬁbres and the homogeneous distribution of PLGA mi-
crospheres in the scaffolds. Furthermore, the detection of single
cells and their distribution in the scaffold could be demonstrated
and was in correspondence with the histological data.
Conclusions: Our scaffold concept offers innovative opportu-
nities for chondrocyte culture in an oriented structure, imitating the
ﬁbre arrangement in articular cartilage. SR-mCT represents a high
resolution three-dimensional imaging method showing cells, scaf-
folds and microspheres, without disturbing the structural integ-
rity of the cell-scaffold construct, and in correspondence with the
histological data.
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The repair of articular cartilage is still a challenging medical
problem and there is a need for the development of a clinically
useful cartilage tissue engineering strategies. A variety of materials
have been suggested for cartilage engineered repair, and injectable
hydrogels are among the most promising alternatives.
This work aimed the exploration of the suitability of chitosan/
glycerol-phosphate/hydroxyethyl cellulose (CGP) hydrogel as
scaffold for cell encapsulation, using ATDC5 cells (murine chon-
drogenic cell line) to produce cartilage-like tissue trough tissue
engineering approach.
A high cell density was encapsulated within the CGP hydrogel
and cultured for up 28 days. The MTS and DNA assays suggest
that CGP hydrogel neither altered cell viability nor proliferation
in three-dimensional culture. The constructs were histologicaly
characterized by H&E staining which revealed that the cells were
uniformly distributed within the hydrogel, they adopted a rounded
morphology, and formed characteristic lacunae around each cell
in the hydrogel. Toluidine Blue and Safranin O stainings also sug-
gest an abundant accumulation of GAG in the extracellular matrix
surrounding the ATDC5 cells cultured in 3D into CGP hydro-
gels, after 4 weeks of culture. The results also evidence an increase
in the synthesis of GAG observed by the DMB quantiﬁcation assay.
The results conﬁrm the potential of the CGP hydrogel as carrier
and support for chondrocyte-like cells. CGP hydrogel induces and
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supports a stable chondrocytic phenotype of ATDC5 cells in vitro,
by promoting the expression of cartilage-speciﬁc markers and the
accumulation of cartilage-speciﬁc extracellular matrix, and thus
showing promising properties for cartilage regeneration.
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Ideal tissue engineering therapy should be achieved by cell and cell
sheet manipulation engineering that would be established with the
following three core technologies: ﬁrst, the noninvasive harvest
of cultured cells and cell sheets are realized with our developed
temperature-responsive culture dishes. The surfaces are hydro-
phobic at 378C, but change to hydrophilic below 328C. Various cell
lines adhere, spread and proliferate on the surfaces similarly to
those on commercial tissue culture dishes. Only by reducing tem-
perature, cells spontaneously detached from the surfaces without
the need for trypsin. Conﬂuent cells are also recovered as a single
contiguous monolayer sheet with deposited extracellular matrix.
Second, the harvested viable cell sheets can be transferred to other
surfaces (2D cell sheet manipulation) because the extracellular
matrix associated with the basal side of cell sheets shows adhesion.
Thus, tissue regeneration with cell sheet tissue engineering can be
accomplished either by transplantation of single cell sheets, as with
skin, cornea and periodontal ligaments. Finally, the recovered cell
sheets can be stratiﬁed to reconstruct complex stratiﬁed tissue ar-
chitectures such as liver lobule, kidney glomeruli, and cardiac
patches (3D cell sheet manipulation). For example, layered cardi-
omyocyte sheets harvested from temperature responsive dishes
pulsate simultaneously and show diffuse gap junction formation.
When transplanted into the subcutaneous tissues of nude rats,
spontaneous beatings could be macroscopically observed after 3
weeks and maintained for over 1 year. We believe that these 2D and
3D cell manipulations, cell sheet tissue engineering, will become
new revolutionary tools for tissue engineering.
(OP 48) Characterization of Early Cardiac-Speciﬁc Transcripts
in Embryonic Stem Cell-Derived Multilineage Progenitors—A
Transcriptional Proﬁling Study
S. Schmitteckert1, H. Schulz2, N. Huebner2, A.M. Wobus3,
A. Rolletschek1,3
1Institute for Biological Interfaces, Forschungszentrum Karlsruhe
GmbH, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-
Leopoldshafen
2Max-Delbrueck Center for Molecular Medicine, D-13125 Berlin,
Robert-Roessle-Str.10
3In Vitro Differentiation Group, Leibniz Institute (IPK) D-06466
Gatersleben, Corrensstr. 3
During in vitro differentiation, embryonic stem (ES) cells reca-
pitulate cellular developmental processes and gene expression
patterns of early embryogenesis. Here, we characterize early stages
of cardiac differentiation of mouse ES cells. ES cells were cultured
as embryoid bodies (EBs) for 5 days (d). After plating EBs were
spontaneously differentiated for 9d into a multilineage progenitor
population representing cells of all three primary germ layers in-
cluding early cardiomyocytes. To investigate this stage of multi-
lineage progenitors and of early cardiac cell types at the transcript
level, microarray analysis was performed using Affymetrix chips
comparing undifferentiated ES cells and 5þ 9d progenitors fol-
lowed by RT-PCR analysis. Transcript levels of transcriptional
regulators (e.g. Tbx20, GATA4, Pitx2), extra-cellular matrix
components (e.g. procollagens I, III, IV, MMPs), and cytoskeletal
proteins (troponins T2 and C, cardiac alpha actin) involved in
cardiac differentiation and function were found to be up regulated.
Speciﬁcally, we detected a subset of up regulated transcripts of
genes known to be speciﬁcally expressed in the cardiac neural crest
or its derivatives. mRNA levels of transcription factors Hand1 and
Hand2, known to control cardiomyocyte-speciﬁc gene expression
through interaction with other transcription factors, and the neural
crest-speciﬁc genes Mef2c, Id2, Lbx1, Efnb1, and Sema3c were
clearly up regulated at this early stage of cardiogenesis. Also, the
presence of the signaling molecule TrkC in this population sug-
gests the involvement of neural crest-speciﬁc genes at an early
stage of cardiac differentiation. Immunocytochemistry is presently
performed to analyse the potential role of cardiac neural crest cells
in early ES-derived cardiogenesis.
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Cardiovascular disease is a leading cause of morbidity and mor-
tality in developed countries. Surgical options remain restricted
secondary to the limitations of prosthetic vascular grafts or inac-
cessibility of adequate autologous vessels. Although large animal
studies have greatly facilitated the development of tissue-
engineered vascular grafts, little is known about the molecular and
cellular mechanisms underlying the remodeling processes of these
grafts. Using sub-1mm tissue engineered vascular grafts composed
of biodegradable poly-L-lactic acid scaffolds statically seeded with
human aortic smooth muscle cells and human endothelial cells
which were implanted into immunodeﬁcient female SCID/bg
mice, we were able to characterize cellular (histologic) composi-
tion of the grafts at various time points and evaluate progression of
graft structure throughout the graft remodeling phase. Thirteen
mice received our tissue-engineered grafts as infra-renal aortic
interposition grafts. The mice were followed to early time points
(4–18 days) as well as later time points (8–30 weeks). Histologic
evaluation of the grafts using species speciﬁc cellular markers
revealed replacement of the human seeded endothelial cells with
those of murine origin. By 8 weeks, there was evidence of sub-
endothelial exracellular matrix protein deposition with active re-
modeling and layering of cellular deposits resembling those of
native mouse aorta. Additionally, all grafts remained patent and
without rupture throughout the study. Although residual polymer
scaffold was present in all samples, progressive aneurysmal dila-
tion was noted at the later time points. Further understanding of
graft remodeling may enable us to target this process and optimize
the grafts for clinical application.
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